One could hypothesize that there may exist a functional hierarchy with BCR/ABL active in committed progenitors and ABL/BCR active at an earlier stage of differentiation, which contributes to the maintenance of the leukemia even upon an efficient BCR/ABL inhibition and the following selection of subclones with BCR/ABL harboring resistance mutations. This evidence concerns the gene ABL1 and leukemia.